Renal cell carcinoma (second line metastatic) - everolimus: appeal
An appeal has been lodged for this appraisal. Below are the papers related to this appeal.
For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.
Renal cell carcinoma (second line metastatic) - everolimus: appeal decision
Renal cell carcinoma (second line metastatic) - everolimus: appeal announcement
Renal cell carcinoma (second line metastatic) - everolimus: notice of appeal
Renal cell carcinoma (second line metastatic) - everolimus: register to attend the appeal
This page was last updated: 06 May 2011
